Department of Urology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea.
BJU Int. 2014 Mar;113(3):408-15. doi: 10.1111/bju.12277. Epub 2013 Aug 13.
To evaluate serial changes in renal function by investigating various clinical factors after radical nephrectomy (RN).
The study population consisted of 2068 consecutive patients who were treated at multiple institutions by RN for renal cortical tumour without metastasis between 1999 and 2011. We measured the serial change in estimated glomerular filtration rate (eGFR) and clinical factors during a 60-month follow-up period. The changes in eGFR over time were analysed according to baseline eGFR (eGFR ≥60 and 15-59 mL/min/1.73m(2) ) using a linear mixed model. The independent prognostic value of various clinical factors on the increase in eGFR was ascertained by multivariate mixed regression model.
Overall, there was a subsequent restoration of renal function over the 60 months. The slope for the relationship between the eGFR and the time since RN was 0.082 (95% confidence interval [CI] 0.039-0.104; P < 0.001) and 0.053 (95% CI 0.006-0.100; P = 0.038) in each baseline group, indicating that each month after RN was associated with an increase in eGFR of 0.082 and 0.053 mL/min/1.73m(2) , respectively. When we analysed renal function based on various factors, postoperative eGFR of patients with diabetes mellitus, old age (≥70 years) or a preoperative eGFR of <30 mL/min/1.73 m(2) , was decreased or maintained at a certain level without any improvement in renal function. Preoperative predictors of an increase in eGFR after RN were young age, no DM, no hypertension, a preoperative eGFR of ≥30 mL/min/1.73m(2) and time after surgery (≥36 months).
Renal function recovered continuously during the 60-month follow-up period after RN. However, the trends in functional recovery change were different according to various clinical factors and such information should be discussed with patients when being counselled about their treatment for renal cell carcinoma (RCC).
通过研究根治性肾切除术(RN)后各种临床因素,评估肾功能的变化。
本研究纳入了 1999 年至 2011 年间在多家机构接受 RN 治疗无转移的肾皮质肿瘤的 2068 例连续患者。在 60 个月的随访期间,我们测量了估算肾小球滤过率(eGFR)的变化,并评估了各种临床因素。使用线性混合模型根据基线 eGFR(eGFR≥60 和 15-59 mL/min/1.73m²)分析了 eGFR 随时间的变化。使用多变量混合回归模型确定各种临床因素对 eGFR 增加的独立预后价值。
总体而言,60 个月后肾功能有一定程度的恢复。eGFR 与 RN 后时间之间的斜率分别为 0.082(95%置信区间 0.039-0.104;P<0.001)和 0.053(95%置信区间 0.006-0.100;P=0.038),这表明 RN 后每个月 eGFR 分别增加 0.082 和 0.053 mL/min/1.73m²。当我们根据各种因素分析肾功能时,患有糖尿病、年龄较大(≥70 岁)或术前 eGFR<30 mL/min/1.73 m²的患者术后 eGFR 降低或维持在一定水平,肾功能无改善。RN 后 eGFR 增加的术前预测因素为年轻、无 DM、无高血压、术前 eGFR≥30 mL/min/1.73m²和手术后时间(≥36 个月)。
RN 后 60 个月的随访期间,肾功能持续恢复。然而,根据各种临床因素,功能恢复的趋势变化不同,在为肾细胞癌(RCC)患者提供治疗建议时,应与患者讨论这些信息。